1. CORESTA Congress, Quebec, 2014, Smoke Science/Product Technology Groups, ST 78

    Predictability of in vitro toxicological assessments of cigarettes: analysis of seven years of regulatory submissions to Canadian authorities

    BELUSHKIN M.(1); PIADÉ J-J.(1); CHAPMAN S.(2); FAZEKAS G.(2)
    (1) Philip Morris International R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (2) Rothmans, Benson & Hedges Inc., Brampton, Ontario, Canada
    Canadian authorities have required the annual submission of a wealth of by-brand information about cigarettes – including analytical data for cut filler and mainstream smoke constituents, for more than a decade. In 2005, the reporting requirements...
  2. CORESTA Congress, Quebec, 2014, Smoke Science/Product Technology Groups, ST 79

    Annual monitoring of a range of cigarette products from the Canadian market and their in vitro biological responses over time (from 2005 to 2013)

    MEGER M.(1); CLEVA BERSAN D.(1); WEBER E.(2); CAMERON P.(3); MILLER-HOLT J.(1); JONES I.(1)
    (1) JT International S.A., Geneva, Switzerland; (2) Ökolab GmbH, Vienna, Austria; (3) JTI Macdonald Corp., Mississauga, ON, Canada
    In vitro toxicity assays have been recognized as valuable tools to assess the biological activity of tobacco products and their emissions. Such data can also be used to compare relative differences in in vitro biological activity between tobacco...